Pharmacyclics, An Abbvie Company

Pharmacyclics, An Abbvie Company company information, Employees & Contact Information

Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based biopharmaceutical company. Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products and a pipeline containing multiple promising new molecules that are being studied in more than 200 clinical trials for over 20 different types of cancer. More than 1,200 Pharmacyclics and AbbVie research scientists, clinicians, marketing, operations and corporate professionals work in the San Francisco Bay Area. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. Together, we are striving to outsmart cancer. Review our LinkedIn community guidelines at http://bit.ly/AbbVieSocialGuidelines.

Company Details

Employees
649
Address
999 East Arques Avenue, Sunnyvale,ca 94085,united States
Phone
408-774-0330
Email
in****@****cyc.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Sunnyvale, CA
Looking for a particular Pharmacyclics, An Abbvie Company employee's phone or email?

Pharmacyclics, An Abbvie Company Questions

News

U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene - Business Wire

U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene Business Wire

Summit Therapeutics: Not Pharmacyclics, Not Yet - Seeking Alpha

Summit Therapeutics: Not Pharmacyclics, Not Yet Seeking Alpha

Company Founded by Cancer-Fighting Chemist Sold for $21 Billion - College of Natural Sciences

Company Founded by Cancer-Fighting Chemist Sold for $21 Billion College of Natural Sciences

With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights - statnews.com

With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights statnews.com

The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Market - MedPage Today

The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Market MedPage Today

Pharmacyclics’ ‘miracle cure’: A cancer drug saves a biotech company - The Seattle Times

Pharmacyclics’ ‘miracle cure’: A cancer drug saves a biotech company The Seattle Times

AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal - Reuters

AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal Reuters

AbbVie to Pay $21 Billion for Pharmacyclics, Maker of a Promising Cancer Drug (Published 2015) - The New York Times

AbbVie to Pay $21 Billion for Pharmacyclics, Maker of a Promising Cancer Drug (Published 2015) The New York Times

AbbVie to Showcase Growing Oncology Portfolio and Commitment to Treating Blood Cancers at the 2016 American Society of Hematology Annual Meeting - PR Newswire

AbbVie to Showcase Growing Oncology Portfolio and Commitment to Treating Blood Cancers at the 2016 American Society of Hematology Annual Meeting PR Newswire

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy - PNAS

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy PNAS

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy - PNAS

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy PNAS

Top Pharmacyclics, An Abbvie Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant